436 related articles for article (PubMed ID: 28099040)
1. Effect of Bacoside A on growth and biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa.
Parai D; Islam E; Mitra J; Mukherjee SK
Can J Microbiol; 2017 Feb; 63(2):169-178. PubMed ID: 28099040
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial agent, Next-Science, inhibits the development of Staphylococcus aureus and Pseudomonas aeruginosa biofilms on tympanostomy tubes.
Banerjee D; Tran PL; Colmer-Hamood JA; Wang JC; Myntti M; Cordero J; Hamood AN
Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1909-14. PubMed ID: 26388185
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
Orazi G; Ruoff KL; O'Toole GA
mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
[No Abstract] [Full Text] [Related]
4. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
5. 3-Amino-4-aminoximidofurazan derivatives: small molecules possessing antimicrobial and antibiofilm activity against Staphylococcus aureus and Pseudomonas aeruginosa.
Das MC; Paul S; Gupta P; Tribedi P; Sarkar S; Manna D; Bhattacharjee S
J Appl Microbiol; 2016 Apr; 120(4):842-59. PubMed ID: 26785169
[TBL] [Abstract][Full Text] [Related]
6. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
[TBL] [Abstract][Full Text] [Related]
7. Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides.
Haney EF; Trimble MJ; Cheng JT; Vallé Q; Hancock REW
Biomolecules; 2018 May; 8(2):. PubMed ID: 29883434
[TBL] [Abstract][Full Text] [Related]
8. 3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine (pytz)-capped silver nanoparticles (TzAgNPs) inhibit biofilm formation of Pseudomonas aeruginosa: a potential approach toward breaking the wall of biofilm through reactive oxygen species (ROS) generation.
Chakraborty P; Joardar S; Ray S; Biswas P; Maiti D; Tribedi P
Folia Microbiol (Praha); 2018 Nov; 63(6):763-772. PubMed ID: 29855854
[TBL] [Abstract][Full Text] [Related]
9. Silver oxynitrate - an efficacious compound for the prevention and eradication of dual-species biofilms.
Lemire JA; Kalan L; Gugala N; Bradu A; Turner RJ
Biofouling; 2017 Jul; 33(6):460-469. PubMed ID: 28521545
[TBL] [Abstract][Full Text] [Related]
10. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
Chen X; Thomsen TR; Winkler H; Xu Y
BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
[TBL] [Abstract][Full Text] [Related]
11. Antibiofilm potential of flavonoids extracted from Moringa oleifera seed coat against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans.
Onsare JG; Arora DS
J Appl Microbiol; 2015 Feb; 118(2):313-25. PubMed ID: 25410525
[TBL] [Abstract][Full Text] [Related]
12. Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
Chan WY; Hickey EE; Page SW; Trott DJ; Hill PB
J Vet Pharmacol Ther; 2019 Nov; 42(6):682-692. PubMed ID: 31503362
[TBL] [Abstract][Full Text] [Related]
13. The activity of ferulic and gallic acids in biofilm prevention and control of pathogenic bacteria.
Borges A; Saavedra MJ; Simões M
Biofouling; 2012; 28(7):755-67. PubMed ID: 22823343
[TBL] [Abstract][Full Text] [Related]
14. Intragenic Antimicrobial Peptide Hs02 Hampers the Proliferation of Single- and Dual-Species Biofilms of
Bessa LJ; Manickchand JR; Eaton P; Leite JRSA; Brand GD; Gameiro P
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340580
[No Abstract] [Full Text] [Related]
15. Biofilm susceptibility to metal toxicity.
Harrison JJ; Ceri H; Stremick CA; Turner RJ
Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial, Biofilm Inhibitory and Anti-infective Activity of Metallic Nanoparticles Against Pathogens MRSA and Pseudomonas aeruginosa PA01.
Aswathanarayan JB; Vittal RR
Pharm Nanotechnol; 2017; 5(2):148-153. PubMed ID: 28440203
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Effects of Violacein against Planktonic Cells and Biofilms of Staphylococcus aureus.
Batista AHM; Moreira ACD; de Carvalho RM; Sales GWP; Nogueira PCN; Grangeiro TB; Medeiros SC; Silveira ER; Nogueira NAP
Molecules; 2017 Sep; 22(10):. PubMed ID: 28946655
[TBL] [Abstract][Full Text] [Related]
18. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa.
Su S; Yin P; Li J; Chen G; Wang Y; Qu D; Li Z; Xue X; Luo X; Li M
J Infect Public Health; 2020 May; 13(5):791-799. PubMed ID: 31813834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
